Elisa OYJ ELISA ORD SHS/ FI0009007884 /
2024-05-24 6:35:39 PM | Chg. - | Volume | Bid5:40:08 PM | Ask5:40:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
41.70EUR | - | 54,713 Turnover: 2.18 mill. |
-Bid Size: - | -Ask Size: - | 6.72 bill.EUR | 5.37% | 17.90 |
GlobeNewswire
05-14
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
GlobeNewswire
03-11
Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitratio...
GlobeNewswire
03-04
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2...
GlobeNewswire
02-26
Nokia’s anyRAN broadens options for commercial Cloud RAN deployment and targets enterprises with par...
GlobeNewswire
02-22
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
02-13
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality...
GlobeNewswire
01-09
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clini...
GlobeNewswire
01-03
HydroGraph’s Graphene Selected by Hawkeye Bio for Use in its Early-Stage Lung Cancer Detection Biose...
GlobeNewswire
2023-12-18
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detec...
GlobeNewswire
2023-11-29
Windsor Launches New Year’s Eve Collection with Multi-Platinum artist-songwriter Megan Moroney